Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Signs Psilocybin Manufacturing Agreement Nov 5 • 5 min read Nova Mentis Life Science Corp. announced that its pending acquisition target, Pilz Bioscience Corp., has entered into a psilocybin manufacturing agreement with a pharmaceutical company with over 800 employees.
MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD Nov 2 • 6 min read MindMed announced the completion and publication of a Phase 1 study on LSD effects.
MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines Oct 30 • 5 min read Mind Medicine (MindMed) Inc. announced that it has closed its previously announced bought deal short form prospectus offering.
Better Plant Receives Health Canada Approval for Plant-Based Antiseptic Skin Ointment Oct 29 • 5 min read Better Plant Sciences Inc. announced that it has received a Natural Health Product number from Health Canada for its plant-based, antimicrobial, antiseptic skin ointment.
MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing Oct 28 • 5 min read Mind Medicine (MindMed) Inc. announced that it has filed a final short form prospectus with the securities commissions or similar authorities in each province of Canada, other than Québec.